Herreros, A.; Pérez-Calatayud, J.; Ballester, F.; Barrera-Gómez, J.; Abellana, R.; Melo, J.; Moutinho, L.; Tagliaferri, L.; Rovirosa, Á.
In Vivo Verification of Treatment Source Dwell Times in Brachytherapy of Postoperative Endometrial Carcinoma: A Feasibility Study. J. Pers. Med. 2022, 12, 911.
https://doi.org/10.3390/jpm12060911
AMA Style
Herreros A, Pérez-Calatayud J, Ballester F, Barrera-Gómez J, Abellana R, Melo J, Moutinho L, Tagliaferri L, Rovirosa Á.
In Vivo Verification of Treatment Source Dwell Times in Brachytherapy of Postoperative Endometrial Carcinoma: A Feasibility Study. Journal of Personalized Medicine. 2022; 12(6):911.
https://doi.org/10.3390/jpm12060911
Chicago/Turabian Style
Herreros, Antonio, José Pérez-Calatayud, Facundo Ballester, Jose Barrera-Gómez, Rosa Abellana, Joana Melo, Luis Moutinho, Luca Tagliaferri, and Ángeles Rovirosa.
2022. "In Vivo Verification of Treatment Source Dwell Times in Brachytherapy of Postoperative Endometrial Carcinoma: A Feasibility Study" Journal of Personalized Medicine 12, no. 6: 911.
https://doi.org/10.3390/jpm12060911
APA Style
Herreros, A., Pérez-Calatayud, J., Ballester, F., Barrera-Gómez, J., Abellana, R., Melo, J., Moutinho, L., Tagliaferri, L., & Rovirosa, Á.
(2022). In Vivo Verification of Treatment Source Dwell Times in Brachytherapy of Postoperative Endometrial Carcinoma: A Feasibility Study. Journal of Personalized Medicine, 12(6), 911.
https://doi.org/10.3390/jpm12060911
